Table 3.

Treatment exposure.

Patient Number	Number of Infusions (T/N/TVEC)
1	4/6/6
2	3/4/3
3	12/28/23
4	4/7/5
5	14/17/15
6	2/2/2
7	5/9/7
8	6/15/14
9	3/4/3
10	3/3/2
11	9/19/16
12	4/5/3
13	6/10/4
14	15/42/42
15	11/14/9
16	6/7/6
17	4/5/3
18	19/33/26
19	9/12/11
20	2/3/2
21	6/15/12
22	2/3/2
23	3/3/2
24	1/12/11
25	2/2/2
26	11/17/11
27	16/49/44
28	5/6/5
29	2/2/1
30	6/4/4
31	13/38/38
32	18/31/26
33	5/5/5
34	6/7/2
35	2/1/1
36	3/5/3
37	14/19/17
38	4/4/2
39	14/15/10

Number of infusions of trabectedin, nivolumab and talimogene laherparepvec (TVEC) per patient.